Viral Vector Manufacturing Market worth $12.8 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89341986 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89341986 Browse in-depth TOC on "Viral Vector Manufacturing Market" 363 - Tables 50 - Figures 332 - Pages Viral Vector Manufacturing Market Scope:   The Plasmid DNA segment accounted for the largest share, by type in the viral vector & plasmid DNA manufacturing market in...

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89341986

Browse in-depth TOC on "Viral Vector Manufacturing Market"
363 - Tables
50 - Figures
332 - Pages

Viral Vector Manufacturing Market Scope:

 

The Plasmid DNA segment accounted for the largest share, by type in the viral vector & plasmid DNA manufacturing market in 2022.

By type, the viral vector & plasmid DNA manufacturing market has been further categorized as viral vector and plasmid DNA. The plasmid DNA segment held the largest share of the global viral vector and plasmid DNA manufacturing market in 2022. This can be attributed to Increasing R&D and the growing launches of plasmid DNA production platforms. Plasmid DNA plays a crucial role in this research and developments. Plasmids are often used in genetic engineering and biotechnology for various purposes, including gene cloning, gene expression, and recombinant protein production.

The downstream manufacturing segment accounted for the largest share of the workflow segment in the viral vector and plasmid DNA manufacturing market in 2022.

Based on workflow, the global viral vector and plasmid DNA manufacturing market has been segmented into upstream manufacturing and downstream manufacturing. The downstream manufacturing segment held the largest market share in 2022. The large share of this segment can be attributed to development of efficient purification techniques and processes that result in high yields of purified products.

The North America region catered the largest share of the viral vector and plasmid DNA manufacturing market in 2022.

The viral vector and plasmid DNA manufacturing market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in viral vector and plasmid DNA manufacturing technologies, and collaborative initiatives contribute to the growth of the viral vector and plasmid DNA manufacturing market in the North America region. Additionally, North America faces a significant burden of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders. The increasing prevalence of chronic diseases in the region drives the demand for viral vector and plasmid DNA manufacturing for both research and clinical applications.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89341986

Viral Vector Manufacturing Market Dynamics:

Drivers:

Restraints:

Opportunities:

Challenges:

Key Market Players:

Key players in the viral vector and plasmid DNA manufacturing market include Lonza Group AG (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Charles River Laboratories International, Inc. (US), Catalent Inc. (US), WuXi AppTec (China), FUJIFILM Corporation (Japan), GenScript Biotech Corporation (US), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Novartis AG (Switzerland), Precision Biosciences (US), Bluebird Bio, Inc. (US), Sartorius AG (Germany), Danaher Corporation (US), SIRON Biotech (Germany), VGXI, Inc. (US), Waisman Biomanufacturing (US), Kaneka Eurogentec S.A. (Belgium), PlasmidFactory GmbH (Germany), ATUM (US), Addgene (US), Cell and Gene Therapy Catapult (UK), Batavia biosciences (Netherlands), and Altogen Biosystems (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=89341986

Recent Developments:

Viral Vector Manufacturing Market Advantages:

Overall, the viral vector manufacturing market offers numerous advantages, including scalability, advanced technology, therapeutic potential, diverse applications, regulatory support, collaborations, investment opportunities, patient impact, market competitiveness, and global reach. These factors contribute to the growth and success of the viral vector manufacturing industry, fostering the development of transformative therapies and driving innovation in healthcare.

Viral Vector Manufacturing Market - Report Highlights:

Related Reports:

Cell Isolation Market - Global Forecasts to 2028

Regenerative Medicine Market - Global Forecasts to 2027

Stem Cell Assay Market - Global Forecasts to 2027

Nucleic Acid Isolation and Purification market - Global Forecasts to 2027

Gene Therapy Market - Global Forecasts to 2027

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/viral-vector-manufacturing-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/viral-vector-manufacturing.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/viral-vector-manufacturing-market-worth-12-8-billion--marketsandmarkets-301848009.html